Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Esomeprazole-Induced Central Fever with Severe Myalgia

View through CrossRef
OBJECTIVE: To report a case of central fever associated with severe myalgia following esomeprazole. CASE SUMMARY: A 64-year-old man presented with intense cephalalgia; severe, diffuse myalgia; and fever (>40°C) after esomeprazole initiation for treatment of gastritis. Five hours after ingestion of the first esomeprazole pill (40 mg), the patient developed fever associated with cephalalgia and myalgia. This condition lasted about 40 hours and disappeared spontaneously. Symptoms partially responded to acetaminophen. Four days later, the patient received a second dose of esomeprazole 40 mg. Subsequently, 4 hours later, fever (>40°C), headache, and difficulty in the movement of all parts of the body recurred. Neurologic examination was negative except for a minor state of disorientation. All reflexes were normal or slightly decreased. No skin lesions or breathing difficulty was noted. Routine blood tests were normal. Again, symptoms resolved spontaneously about 40 hours later. DISCUSSION: The temporal connection between esomeprazole intake and the onset of fever suggests a probable causal link, as confirmed by the Naranjo probability scale. However, the pathogenic mechanism remains unclear. Considering that esomeprazole is able to cross the blood—brain barrier, its peak serum concentration is reached 90–180 minutes after oral administration, and its serum half-life is approximately 2 hours, we assume that the appearance of fever with accompanying neurologic and muscular symptoms might result from the drug interference with the hypothalamic regulatory center of body temperature. CONCLUSIONS: Hyperpyrexia of central origin associated with intense cephalalgia and myalgia may occur as an adverse effect of esomeprazole therapy.
Title: Esomeprazole-Induced Central Fever with Severe Myalgia
Description:
OBJECTIVE: To report a case of central fever associated with severe myalgia following esomeprazole.
CASE SUMMARY: A 64-year-old man presented with intense cephalalgia; severe, diffuse myalgia; and fever (>40°C) after esomeprazole initiation for treatment of gastritis.
Five hours after ingestion of the first esomeprazole pill (40 mg), the patient developed fever associated with cephalalgia and myalgia.
This condition lasted about 40 hours and disappeared spontaneously.
Symptoms partially responded to acetaminophen.
Four days later, the patient received a second dose of esomeprazole 40 mg.
Subsequently, 4 hours later, fever (>40°C), headache, and difficulty in the movement of all parts of the body recurred.
Neurologic examination was negative except for a minor state of disorientation.
All reflexes were normal or slightly decreased.
No skin lesions or breathing difficulty was noted.
Routine blood tests were normal.
Again, symptoms resolved spontaneously about 40 hours later.
DISCUSSION: The temporal connection between esomeprazole intake and the onset of fever suggests a probable causal link, as confirmed by the Naranjo probability scale.
However, the pathogenic mechanism remains unclear.
Considering that esomeprazole is able to cross the blood—brain barrier, its peak serum concentration is reached 90–180 minutes after oral administration, and its serum half-life is approximately 2 hours, we assume that the appearance of fever with accompanying neurologic and muscular symptoms might result from the drug interference with the hypothalamic regulatory center of body temperature.
CONCLUSIONS: Hyperpyrexia of central origin associated with intense cephalalgia and myalgia may occur as an adverse effect of esomeprazole therapy.

Related Results

Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
(1) Background: In critically ill cardiac patients, parenteral and enteral food and drug administration routes may be used. However, it is not well known how drug absorption and me...
A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis
A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis
OBJECTIVES: Proton pump inhibitors have dose-dependent immunomodulatory effects. We tested the hypothesis that mega-dose esomeprazole therapy would reduce organ dysfunc...
Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral deliv...
Challenges in diagnosis and follow-up of chronic Q fever
Challenges in diagnosis and follow-up of chronic Q fever
Coxiella burnetii is the causative pathogen of the zoonosis Q fever. Upon primary infection, patients can remain asymptomatic or experience the disease called acute Q fever. After ...
A Novel Analytical approach for Simultaneous Estimation of Esomeprazole and Ondansetron by HPLC-DAD Method with Degradation Studies
A Novel Analytical approach for Simultaneous Estimation of Esomeprazole and Ondansetron by HPLC-DAD Method with Degradation Studies
Objective: A simultaneous estimation of Esomeprazole and Ondansetron by HPLC-DAD method with degradation studies was developed. Method: It was carried out using Kromasil (150mm×4.6...
Fever with Special Emphasis on Neurogenic Fever in Traumatic Brain Injury Patients Admitted to the Trauma ICU: A Prospective Cohort Study
Fever with Special Emphasis on Neurogenic Fever in Traumatic Brain Injury Patients Admitted to the Trauma ICU: A Prospective Cohort Study
Background: Fever is a common and challenging problem in traumatic brain injury (TBI) patients in the intensive care unit (ICU), and distinguishing neurogenic fever (NF) from infec...
Aetiology of fever in patients with acute stroke *
Aetiology of fever in patients with acute stroke *
Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K (University of Athens School of Medicine, ‘Alexandra’ Hospital, Athens, Greece; Harvard School of Public Health, Boston...

Back to Top